VEGFA and cancer: The possibility that specific VEGF-SNPs may be related to the development of VTE was raised from a comparative study in 2006 [53], indicating a difference in the distribution of VEGF-A + 936 C/T between cancer patients who developed or did not develop VTE (OR = 2.3, 95% CI, 0.9–5.7).